Details
Search

SHOW ABSTRACT TEXT

Opening Reception/Posters/Exhibits
Poster Session   |  Exhibit Hall - Riverwalk AB
Aug 23, 2020 from 5:45 PM to 6:30 PM

   
47
    
Recognizing reasons of unwarranted coagulation testing in medically ill patients - a sneak peek  
Sidra Asad Ali, Amir Khan, Naila Noor 

48
    
Leveraging Turbidimetry and Thromboelastography to Characterize Fibrin Formation under Diverse Clotting Conditions  
Ziqian Zeng, Mahussi Fagnon, Tanmaye Nallan Chakravarthula, Nathan / J Alves 

49
    
Identify the knowledge, attitude and practice of healthcare providers toward prescribing factor replacement at Federally Funded Hemophilia Treatment Centers in the United States.  
Maya Bloomberg, Krysten Sargenton, Karina Gattamorta, Debbie Anglade 

50
    
Profile of Inflammatory Biomarkers and Coagulation Factors in End-Stage Renal Disease  
Emily Bontekoe, Arjun Grewal, Vinod Bansal, Debra Hoppensteadt, Melissa Mazariegos, Jawed Fareed 

51
    
Coagulation profile derangement and disease severity/spectrum in pediatric population  
Asma N Cheema, Syeda Saima Irshad, Muhammad Aamer Sujjad, Muhammad Gulsher 

52
    
Performance Characteristics of a Chromogenic Factor VIII Method on the STA-R Evolution XP  
Ronda A Crist, Daniel A Stephens, George M Rodgers, Jessica Corean, Karen A Moser, Kristi J Smock 

53
    
The Development and Impact of a Hemostatic Stewardship Program at Two Large Academic Medical Centers  
Kathryn Dane, John Lindsley, Satish Shanbhag, Michael Streiff 

54
    
Association of Hypercoagulable State with Clinical Severity of Sickle Cell Disease in Sudanese Patients  
Alaaeddin M. Elzubeir, Shima H. Elsheikh, Tayseer A. Alabid 

55
    
Evaluation of a Rapid Automated Chemiluminescent ADAMTS13 Activity Assay for the ACL AcuStar  
R Fretwell, T Pitchford, SM Cooper, S Kitchen 

56
    
EFFECTS OF TAI CHI ON BALANCE IN INDIVIDUALS LIVING WITH HEMOPHILIA  
Mark Krimmel, Rebecca Kruse-Jarres, Bruno Steiner 

57
    
Effect of human plasma on evaluation of coagulation factor VIII product purity by Western Blot  
Yideng Liang, Mohammad B Uddin, Alexey V Khrenov, Sergey S Akimov, Timothy K Lee, Mikhail V Ovanesov 

58
    
Knockdown of hepatic TAFI or A2AP by GalNAc-siRNA strategy expedited thrombolysis in a rodent large-vein electrolytic injury model  
Jingxuan Liu, Brian Cooley, Akin Akinc, Anna Borodovsky, Patrick Haslett 

59
    
Influence of DOAC Remove on coagulation assays in samples from patients on anticoagulation  
Zahra Al-Qawzai, Nada Yartey, Chris Dale, Minal Dave, Sean Platton 

60
    
CRYOcheck™ Chromogenic Factor VIII: A New Kit for the Determination of Factor VIII:C Activity  
Tara Quinton, Karen M. Black, Ali Sadeghi-Khomami 

61
    
Performance of CRYOcheck™ Chromogenic Factor VIII in the Recovery of Factor VIII Replacement Therapies  
Tara Quinton, Karen M. Black, Ali Sadeghi-Khomami 

62
    
Development and Performance Characterization of an Automated Chromogenic Assay for Human Factor IX Activity  
Narayanan Ramamurthy, Sean Duffin, Cheryl Kucharshi, Zach Vandertuin, Michael Morris 

63
    
Mathematical Modeling of Impacts of Variable Hematocrit and Blood Collection Fill Volume on Citrated Plasma For Coagulation Testing  
Jay S. Raval, Marian A. Rollins-Raval, Richard A. Marlar 

64
    
Efficacy and safety of N8-GP for prophylaxis and bleed control in US vs global patients with hemophilia A: results from the pathfinder clinical program  
Allison P. Wheeler, Miguel Escobar, Susan Kearney, Leslie Raffini, Janice M. Staber, Suchitra Acharya, David L. Cooper, Steven Lentz 

65
    
Pharmacovigilance of von Willebrand factor/coagulation FVIII complex (Human)- 10 years' experience  
Claudio Sandoval, Azim Saifee, Dipen Patel, Huub Kreuwel 

66
    
Von Willebrand Disease in pregnancy and the use of epidural analgesia  
Maissaa Janbain, MD, Radia Ksayer, MD, Anna Swigert, BS 

67
    
A Role for Nurses: Hospital-wide roll out of Extremity Precautions for New Finding of Extremity Thrombosis procedure at a pediatric tertiary care setting - a quality improvement initiative  
Marilyn Blumenstein, Emily Roberto 

68
    
Pharmacokinetics of recombinant von Willebrand factor in peripartum management of an adolescent with Type 2M von Willebrand Disease  
Caitlin Montcrieff 

69
    
Retrospective Analysis of Ten Years of PT and aPTT Validation Data in a Reference Lab  
Dan A Stephens, Ronda A Crist, George M Rogers, Kristi J Smock, Karen Moser